MyAverix Finance
NS · Healthcare
Parmax Pharma Ltd (540359)
Pharmaceuticals & Biotechnology
Parmax Pharma Ltd (540359) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $270.00M, P/E ratio is -6.49, net margin is -31.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 540359
Parmax Pharma Ltd (540359) — FAQ
What is Parmax Pharma Ltd's market cap?
Parmax Pharma Ltd (540359) has a reported market cap of $270.00M (data as of 2026-07-10).
What is 540359's P/E ratio?
The price-to-earnings (P/E) ratio for Parmax Pharma Ltd (540359) is -6.49 (data as of 2026-07-10).
Does Parmax Pharma Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Parmax Pharma Ltd (540359). Check the MyAverix Finance app for the latest dividend data.
What sector is Parmax Pharma Ltd in?
Parmax Pharma Ltd (540359) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 540359 listed on?
540359 is listed on NS.
What is Parmax Pharma Ltd's net margin?
Parmax Pharma Ltd (540359) reports a net margin of -31.1% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.